U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 01:22:51 GMT 2025
Edited
by admin
on Wed Apr 02 01:22:51 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
LSX3UPC7JY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
YH-001
Preferred Name English
Futermestotug
INN  
Official Name English
YH 001 [WHO-DD]
Common Name English
immunoglobulin G1-kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], humanized monoclonal antibody;
Common Name English
RECOMBINANT HUMANIZED ANTI-CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4 (ANTI-CTLA4) IGG1 MONOCLONAL ANTIBODY
Common Name English
futermestotug [INN]
Common Name English
YH001
Code English
Immunoglobulin G1, anti-(human/Macaca mulatta CTLA-4 antigen) (human-Mus musculus monoclonal YH001 ?1-chain), disulfide with human-Mus musculus monoclonal YH001 ?-chain, dimer
Common Name English
H-gamma1 heavy chain humanized (1-452) [VH (Homo sapiens IGHV3-23*04 (90.8%) -(IGHD) -IGHJ4*01 (80.0%) S128>A (122), CDR-IMGT [8.8.15] (26-33.51-58.97-111)) (1-122) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (219)
Common Name English
Code System Code Type Description
NCI_THESAURUS
C176873
Created by admin on Wed Apr 02 01:22:51 GMT 2025 , Edited by admin on Wed Apr 02 01:22:51 GMT 2025
PRIMARY
SMS_ID
300000046937
Created by admin on Wed Apr 02 01:22:51 GMT 2025 , Edited by admin on Wed Apr 02 01:22:51 GMT 2025
PRIMARY
FDA UNII
LSX3UPC7JY
Created by admin on Wed Apr 02 01:22:51 GMT 2025 , Edited by admin on Wed Apr 02 01:22:51 GMT 2025
PRIMARY
CAS
3014361-57-7
Created by admin on Wed Apr 02 01:22:51 GMT 2025 , Edited by admin on Wed Apr 02 01:22:51 GMT 2025
PRIMARY
INN
13465
Created by admin on Wed Apr 02 01:22:51 GMT 2025 , Edited by admin on Wed Apr 02 01:22:51 GMT 2025
PRIMARY
From To
1_22 1_96
1_149 1_205
1_225 3_214
1_231 2_231
1_234 2_234
1_266 1_326
1_372 1_430
2_22 2_96
2_149 2_205
2_225 4_214
2_266 2_326
2_372 2_430
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_302
N 2_302
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_452] [2_452] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL